Gregory Moore, MD
Interventional Pain Medicine · Eugene, ORNPI 1457496705
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $238,613 of the $377,163 with a category attached, or 63.3%. 28 manufacturers reported payments, led by Relievant Medsystems, Inc. at 42.2% of the total. Among interventional pain medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 796 payments — averaging $473.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$159K
- Boston Scientific$134K
- Aurora Spine, Inc.$28K
- Medtronic$16K
- Abbott$15K
- MML US, Inc.$10K
- plus $15K from 22 others
Across 247 payments — averaging $5544.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$531K
- Nalu Medical, Inc.$348K
- MML US, Inc.$212K
- Abbott$115K
- Relievant Medsystems, Inc.$56K
- Vertex$52K
- plus $55K from 3 others
What the payments were for
- Consulting fees$85,58923%
- Speaking & faculty fees$238,61363%
- Travel & lodging$31,9798%
- Food & beverage$19,9595%
- Education$1,0240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 163 | $159,283 |
| Boston Scientific | 224 | $133,883 |
| Aurora Spine, Inc. | 9 | $28,490 |
| Medtronic(2 entities) | 80 | $15,855 |
| Abbott | 173 | $14,644 |
| MML US, Inc. | 27 | $9,803 |
| Vertos Medical, Inc. | 6 | $7,744 |
| Painteq LLC | 31 | $3,114 |
| Saluda Medical Americas, Inc. | 15 | $1,478 |
| Curonix LLC | 7 | $590 |
| Nalu Medical, Inc. | 17 | $481 |
| Biotronik NRO, Inc. | 7 | $473 |
| Spinal Simplicity, LLC | 8 | $400 |
| Vertiflex, Inc. | 4 | $224 |
| SPR Therapeutics, Inc | 3 | $141 |
| Trice Medical, Inc. | 2 | $136 |
| AbbVie(2 entities) | 4 | $75 |
| Stryker | 1 | $73 |
| Nevro Corp. | 4 | $66 |
| Spinefrontier, Inc. | 1 | $59 |
| Bioventus LLC | 1 | $24 |
| Amgen | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Foundation Fusion Solutions, LLC | 2 | $18 |
| Vertex | 1 | $18 |
| Merit Medical Systems Inc | 2 | $17 |
| Stimwave Technologies Incorporated | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$467,957
- ZIP$28,490
- Superion Indirect Decompression System$11,589
- ReActiv8$9,402
- GENERAL - THERAPIES$9,147
- mild Device Kit$7,420
- WAVEWRITER ALPHA$6,379
- PROCLAIM$5,874
- KYPHON EXPRESS II KYPHOPAK TRAY$5,638
- Neuromodulation Dspsbls and Accs$4,462
- GENERAL PAIN MANAGEMENT$2,448
- PAINTEQ$2,286
- WaveWriter Alpha Prime 16$1,700
- Evoke$1,000
- OSTEOCOOL RF ABLATION SYSTEM$620
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$462
- Axium$382
- Proclaim Family of SCS IPGs$342
- VANTA ADAPTIVESTIM$279
- OSTEOCOOL RF ABLATION$271
How this compares
$377,163 in reported general payments places this provider in the 95th percentile of 22 interventional pain medicine providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 27 | $522 |
| Oxycodone Hcl | 15 | $175 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Eugene
- Gregory PhillipsEugene$50K
- Stephen PeirceEugene$28K
- Rishi VoraEugene$16K
- Joseph DunnEugene$10K
- Donna MorganEugene$9K
- George JohnstonMedford$14K
- Poly ChenSalem$14K
- Kwo Wei HoTigard$13K
- Carl BalogPortland$12K
- Vladimir FiksPortland$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.